Pancreatic Cancer Research

ResearcherUniversity of TorontoNo recent work listed

Kelly Lien

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9494-3776; OpenAlex author ID A5053561819. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper

Papers 3

  1. Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System. Co-author DOI 10.1016/j.jval.2016.11.002↗
  2. Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer. Co-author DOI 10.3747/co.22.2592↗
  3. A Bayesian meta-analysis of multiple treatment comparisons of systemic regimens for advanced pancreatic cancer. Co-author DOI 10.1371/journal.pone.0108749↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kelvin Chan · 3 shared papers, 2014–2017 · strength 0.18
  2. Yoo‐Joung Ko · 2 shared papers, 2014–2017 · strength 0.12
  3. Doug Coyle · 2 shared papers, 2014–2017 · strength 0.12
  4. Vincent Channing Tam · 1 shared paper, 2015 · strength 0.06
  5. Y.J. Ko · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.